Labat AfricaJSE:LAB +66.67% FCF Margin % is 29.75% as of Nov. 2025. The stock has 5 warning signs investors should review. Among 958 Drug Manufacturers companies, Labat Africa ranks better than 65.76% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Labat Africa's Free Cash Flow for the
six
months ended in Nov. 2025 was R44.9 Mil. Labat Africa's Revenue for the
six
months ended in Nov. 2025 was R150.9 Mil. Therefore, Labat Africa's FCF Margin % for the quarter that ended in Nov. 2025 was 29.75%.
The historical rank and industry rank for Labat Africa's FCF Margin % or its related term are showing as below:
JSE:LAB'
s FCF Margin % Range Over the Past 10 Years
Min: -31.19 Med: -1.78 Max: 175.68
Current: 8.25
During the past 13 years, the highest FCF Margin % of Labat Africa was 175.68%. The lowest was -31.19%. And the median was -1.78%.
JSE:LAB's FCF Margin % is ranked better than 65.76% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs JSE:LAB: 8.25
Labat Africa FCF Margin % Related Terms
Labat Africa FCF Margin % Historical Data
* Premium members only.
The historical data trend for Labat Africa's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:LAB vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labat Africa FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labat Africa's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Labat Africa's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labat Africa (JSE:LAB) has a FCF Margin % of 29.75% as of Nov. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Labat Africa and its competitors. According to the industry distribution chart, Labat Africa ranks #328 out of 958 companies in the Drug Manufacturers industry, placing it in the top 34.2%.
Is Labat Africa's FCF Margin % too high?
Labat Africa's current FCF Margin % is 29.75%. The Drug Manufacturers industry median FCF Margin % is 2.51. Labat Africa's value of 29.75% is 1085.3% above this industry median. Based on the distribution chart, Labat Africa ranks #328 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Labat Africa's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #328 out of 958 companies for FCF Margin %. This puts Labat Africa in the upper half of its industry. The industry median FCF Margin % is 2.51. Labat Africa's value of 29.75% is 1085.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labat Africa's current FCF Margin % of 29.75% is 1085.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Labat Africa and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current FCF Margin % is 29.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current FCF Margin % is 29.75% and 1085.3% above the Drug Manufacturers industry median of 2.51. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current FCF Margin % is 29.75% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:LAB has been successfully added to your 